03.09.10
Morinaga Milk Industry Co., Ltd., Tokyo, Japan, has received a no objection letter from FDA in response to its GRAS (Generally Recognized as Safe) notification for the proprietary probiotic strain Bifidobacterium longum BB536. The official FDA affirmation that the ingredient is GRAS paves the way for the highly researched probiotic to be included in functional foods. Numerous published human clinical trials have found that BB536 provides a natural defense against episodic digestive upsets, including constipation, diarrhea, abdominal discomfort, gas and bloating.
